Long-lasting decrease of CD4+/CD45RA+ T cells in HCL patients after 2-chlorodeoxyadenosine (2-CdA) treatment

Leukemia

Volumn 13, Issue 8, 1999, Pages 1254-1257

  Raspadori, D ^a   Rondelli, D ^b   Birtolo, S ^b   Lenoci, M ^b   Nardi, G ^b   Scalia, G ^b   Sestigiani, C ^b   Tozzi, M ^b   Marotta, G ^b   Lauria, F ^b  

^a Ospedale A Sclavo   (Italy)

^b NONE

Author keywords

2 CdA; CD4+ CD45RA+; CD4+ CD45RO+; HCL

Indexed keywords

CD4 ANTIGEN; CD45 ANTIGEN; CLADRIBINE; RECOMBINANT ALPHA INTERFERON;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HAIRY CELL LEUKEMIA; HUMAN; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; STAINING; T LYMPHOCYTE SUBPOPULATION; TIME; TREATMENT OUTCOME;

EID: 0032869495     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401476     Document Type: Article

References (26)

1. Hamann D, Baars PA, Hooibrink B, van Lier RAW. Heterogeneity of the human CD4+ T-cell population: two distinct CD4+ T-cell subsets characterized by compression of CD45RA and CD45RO isoforms. Blood 1996; 88: 3513-3521.
2. Akbar AN, Terry L, Timms A, Beverly PC, Janossy G. Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells. J Immunol 1988; 140: 2171-2175.
3. Akbar AN, Salmon M, Ivory K, Taki S, Pilling D, Janossy G. Human CD4+CD45RO+ and CD4+CD45RA+ T cells synergize in response to alloantigens. Eur J Immunol 1991; 21: 2517-2520.
4. Clement LT, Yamashita N, Martin AM. The functionally distinct subpopulations of human CD4+helper/inducer T lymphocytes defined by anti-CD45R antibodies derive sequentially from a differentiation pathway that is regulated by activation-dependent post-thymic differentiation. J Immunol 1988; 141: 1464-1467.
5. Johannisson A, Festin R. Phenotype transition of CD4+ T cells from CD45RA to CD45RO is accompanied by cell activation and proliferation. Cytometry 1995; 19: 343-352.
6. Kristensson K, Dohlsten M, Fischer H, Ericsson PO, Hedlund G, Sjogren HO, Carlsson R. Phenotypical and functional differentiation of CD4+CD45RA+ human T cells following policlonal activation. Scand J Immunol 1990; 32: 243-253.
7. Picker LJ, Treer JR, Ferguson-Darnell B, Collins PA, Buck D, Terstappen LWMM. Control of lymphocyte regulation in man I. Differential regulation of the peripheral lymph node homing receptor L-selectin on T-cells during the virgin to memory transition. J Immunol 1993; 150: 1105-1109.
8. Wallace DL, Beverly PCL. Phenotypic changes associated with activation of CD45RA+ and CD45RO+ T cells. Immunology 1990; 69: 460-464.
9. Sanders ME, Makgoba MW, Sharrow SO, Stephany D, Springer TA, Young HA, Shaw S. Human memory T lymphocytes express increased levels of three adhesion molecules (LFA-3, CD2, and LFA-1) and three other molecules (UCHL-1, CDw29, and Pgp-1) and have enhanced IFN-gamma production. J Immunol 1988; 140: 1401-1407.
10. Kristensson K, Borrebaeck CA, Carlsson R. Human CD4+ T cells expressing CD45RA acquire the lymphokine gene expression of CD45RO+ T-helper cells after activation in vitro. Immunol 1992; 76: 103-109.
11. + T cells expressing IL-2 receptor alpha-chain (CD25) and having a functionally transitional nature into memory cells, Int Immunol 1991; 3: 1349-1356.
12. Buckle AM, Hogg N. Human memory T cells express intercellular adhesion molecule-1 which can be increased by interleukin-2 and interferon-gamma. Eur J Immunol 1990; 20: 337-342.
13. Lauria F, Foà R, Gobbi M, Pulvirenti A, Raspadori D, Giubellino MC. Characterization of T-lymphocyte subsets in hairy-cell leukaemia (HCL) by monoclonal antibodies: comparison with Fcγ, Fcμ receptors and correlation with disease activity. Br J Haematol 1982; 52:657-662.
14. Ruco LP, Procopio A, Maccallini V, Calogero A, Uccini S, Annino L, Mandelli F, Barono CD. Severe deficiency of natural killer activity in the peripheral blood of patients with hairy cell leukemia. Blood 1983; 61: 1132-1137.
15. Van der Horst FAL, van der Marel A, den Ottolander GJ, Kluin-Nelemans HC. Decrease of memory T helper cells (CD4+/CD45RO+) in hairy cell leukemia. Leukemia 1993; 7: 46-50.
16. Estey EH, Kurzrock R, Kantarjian HM, O'Brien SM, McKredie KB, Beran M, Koller C, Keating MJ, Hirsck-Ginsberg C, Huh YO. Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA). Blood 1992; 79: 882-887.
17. Piro LD, Carrera CJ, Carson DA, Beutler E. Lasting remission in hairy cell leukemia induced by a single infusion of 2-chlorodeoxy-adenosine. New Engl J Med 1990; 332: 1117-1121.
18. Lauria F, Rondelli D, Zinzani PL, Bocchia M, Marotta G, Raspadori D, Ventura MA, Birtolo S, Forconi F, Tura S. Long-lasting complete remission in patients with hairy cell leukemia treated with 2-CdA: a 5-year survey. Leukemia 1997; 11: 629-632.
19. Lauria F, Bocchia M, Marotta G, Raspadori D, Zinzani PL, Rondelli D. Weekly administration of 2-chlorodeoxyadenosine in patients with hairy cell leukemia: a new treatment schedule effective and safer in preventing infectious complications. Blood 1997; 89: 1838-1839.
20. Seymour JF, Kurzrock R, Freireich EJ, Estey EH. 2-Chlorodeoxyadenosine induces durable remissions and prolonged suppression of CD4+ lymphocyte counts in patients with hairy cell leukemia. Blood 1994; 83: 2906-2911.
21. Juliusson G, Lenkei R, Liliemark J. Flow cytometry of blood and bone marrow cells from patients with hairy cell leukemia: pheno-type of hairy cells and lymphocytes subsets after treatment with 2-chlorodeoxyadenosine. Blood 1994; 83: 3672-3681.
22. Mackall CL, Fleischer A, Brown M, Magrath IT, Wexler LH, Horowitz ME, Cress RE, Andrich M, Chen C, Feuerstein I. Age, thymopoiesis, and CD4+ T-lymphocyte regeneration following chemotherapy. New Engl J Med 1995; 332: 143-149.
23. Hakim FT, Cepeda R, Kaimei S, Mackall CL, McAtee N, Zujewski J, Cowan K, Gress RE. Constraints on CD4 recovery postchemotherapy in adults: thymic insufficiency and apopototic decline of expanded peripheral CD4 cells. Blood 1997; 90: 3789-3798.
24. Mackall CL, Gress RE. Pathways of T-cell regeneration in mice and humans: implications for bone marrow transplantation and immunotherapy. Immunol Rev 1997; 157: 61-72.
25. Seymour JF, Talpaz M, Kurzrock R. Response duration and CD4+ lymphocytes following deoxycoformycin in interferon-α-resistant hairy cell leukemia: a 7-years follow-up. Leukemia 1997; 11: 42-47.
26. Schwinzer R, Siefken R. CD45RA+ and CD45RO+ T cells differ in susceptibility to cyclosporin A mediated inhibition of interleukin-2 production. Transpl Immunol 1996; 4: 61-63.